Kristina Vlaovic, Vice President of Regulatory & Safety

Ms. Vlaovic joined Halozyme in 2015 as Vice President of Regulatory & Safety. Prior to her arrival at Halozyme, she was the global regulatory head for Genentech’s ophthalmology and respiratory franchises. Preceding her experience at Genentech, she has more than 15 years of industry experience at companies such as Amgen, InterMune and Pfizer, leading and implementing strategic regulatory paths for products such as Lucentis®, Enbrel®, Esbriet® and Sutent®, as well as development strategies for numerous Phase 1-3 molecules. Ms. Vlaovic received her BS and MPH from the University of Michigan.


You are now leaving Halozyme is not responsible for or endorses the content of the linked site.